Hospitals in the UK are failing to inform patients when doctors responsible for choosing their drugs have received money from pharmaceutical companies, finds a new study in the British Medical Journal.
It is not news that officials in the UK’s National Health Service (NHS) are on the payroll of the Pharma Cartel. An investigation in 2016 found that more than 130 officials employed by the NHS were simultaneously being paid as consultants by pharmaceutical companies. Significantly, the officials concerned were directly involved in assessing which drugs the NHS should give to patients. Suggesting the actual number taking money from the pharma industry may be even higher, the Daily Telegraph, the British newspaper that uncovered the story, described the problem as being “systemic” within the NHS.
Worse still however, not only are such conflicts of interest now a worldwide problem, the drug industry habitually rigs the results of the ‘studies’ it carries out. To learn how we are being deliberately misled about the safety and effectiveness of drug-based medicine, read this article on our website.